Related Experiment Video

Updated: May 19, 2026

Experimental Endocarditis Model of Methicillin Resistant Staphylococcus aureus (MRSA) in Rat
07:46

Experimental Endocarditis Model of Methicillin Resistant Staphylococcus aureus (MRSA) in Rat

Published on: June 4, 2012

Implantable cardioverter defibrillator lead-related methicillin resistant Staphylococcus aureus endocarditis:

Obiora F Anusionwu1, Cheri Smith, Alan Cheng

  • 1Obiora F Anusionwu, Division of Hospital Medicine, Johns Hopkins University School of Medicine, Baltimore, MD 21224, United States.

World Journal of Cardiology
|August 21, 2012
PubMed

Insights

Methicillin-resistant Staphylococcus aureus (MRSA) septicemia from cardiac device infections poses serious risks. Early recognition and excimer laser lead extraction are crucial for successful patient outcomes.

Area of Science:

  • Infectious Diseases
  • Cardiology
  • Medical Devices

Background:

  • Methicillin-resistant Staphylococcus aureus (MRSA) septicemia presents significant morbidity and mortality risks, particularly in immunocompromised patients, diabetics, and those with renal disease or endocarditis.
  • The increasing use of cardiac implantable electronic devices (CIEDs) correlates with a rise in device-lead associated endocarditis.
  • Optimizing patient outcomes necessitates a high index of suspicion for MRSA septicemia in CIED infections.

Purpose of the Study:

  • To present an unusual case of MRSA septicemia originating from device-lead endocarditis.
  • To review the literature concerning MRSA septicemia in the context of CIEDs.
  • To emphasize the importance of early diagnosis and prompt treatment for MRSA device-lead endocarditis.

Main Methods:

  • Case report presentation.
  • Comprehensive literature review on MRSA septicemia and CIED infections.
  • Discussion of treatment modalities, including excimer laser lead extraction.

Main Results:

  • The case highlights a challenging scenario of MRSA septicemia secondary to CIED infection.
  • Literature review confirms the association between CIEDs and increased risk of endocarditis.
  • Excimer laser extraction demonstrated efficiency in managing infected leads.

Conclusions:

  • Early recognition and prompt treatment are vital for managing MRSA septicemia from CIED infections.
  • Excimer laser technology offers a valuable tool for successful lead extraction in these complex cases.
  • Vigilance for MRSA septicemia in patients with CIEDs is essential for improved patient management and prognosis.
Keywords:
EndocarditisImplantable cardioverter-defibrillatorMethicillin resistant Staphylococcus aureusPacemakersSepsis

More Related Videos

A New Single Chamber Implantable Defibrillator with Atrial Sensing: A Practical Demonstration of Sensing and Ease of Implantation16:40

A New Single Chamber Implantable Defibrillator with Atrial Sensing: A Practical Demonstration of Sensing and Ease of Implantation

Published on: February 28, 2012

An In Vitro Model of a Parallel-Plate Perfusion System to Study Bacterial Adherence to Graft Tissues07:50

An In Vitro Model of a Parallel-Plate Perfusion System to Study Bacterial Adherence to Graft Tissues

Published on: January 7, 2019

Related Concept Videos

Endocarditis III: Medical Management01:18

Endocarditis III: Medical Management

Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
Endocarditis I: Introduction01:25

Endocarditis I: Introduction

Introduction:Endocarditis is the infection of the endocardium, the inner lining of the heart and its valves. When the heart muscle is involved, the condition is termed myocarditis, while an infection of the outer lining is called pericarditis. Infective endocarditis (IE) primarily affects the endocardium, where pathogens adhere to the valves or lining, forming vegetation that can lead to severe complications. Infective endocarditis occurs when microorganisms, usually bacteria from other body...
Endocarditis IV: Nursing Management01:29

Endocarditis IV: Nursing Management

Infective endocarditis (IE) is a chronic infection of the heart's endocardium, primarily affecting the heart valves. A detailed nursing assessment for a patient with IE involves collecting subjective and objective data to ensure an accurate diagnosis and timely intervention.Subjective DataThe nurse gathers information about the patient's symptoms and complaints during the subjective assessment. Patients with infective endocarditis often report non-specific symptoms that can mimic other...
Endocarditis II: Clinical Features of Infective Endocarditis01:25

Endocarditis II: Clinical Features of Infective Endocarditis

Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...